Squarepoint’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,317
Closed -$130K 3078
2024
Q4
$130K Buy
+9,317
New +$130K ﹤0.01% 2496
2024
Q2
Sell
-2,585
Closed -$36.2K 2812
2024
Q1
$36.2K Sell
2,585
-5,959
-70% -$83.5K ﹤0.01% 2343
2023
Q4
$72.4K Buy
+8,544
New +$72.4K ﹤0.01% 2321
2023
Q3
Sell
-54,320
Closed -$469K 2713
2023
Q2
$469K Buy
54,320
+8,952
+20% +$77.2K ﹤0.01% 1624
2023
Q1
$478K Buy
45,368
+42,283
+1,371% +$446K ﹤0.01% 1489
2022
Q4
$105K Sell
3,085
-5,763
-65% -$195K ﹤0.01% 2051
2022
Q3
$425K Buy
+8,848
New +$425K ﹤0.01% 1461
2022
Q2
Sell
-9,615
Closed -$777K 2463
2022
Q1
$777K Sell
9,615
-1,094
-10% -$88.4K ﹤0.01% 1257
2021
Q4
$2.17M Buy
10,709
+9,917
+1,252% +$2.01M 0.01% 826
2021
Q3
$213K Sell
792
-5,108
-87% -$1.37M ﹤0.01% 1792
2021
Q2
$1.52M Buy
5,900
+4,587
+349% +$1.18M 0.01% 934
2021
Q1
$394K Sell
1,313
-821
-38% -$246K ﹤0.01% 1696
2020
Q4
$544K Sell
2,134
-1,846
-46% -$471K ﹤0.01% 1451
2020
Q3
$990K Buy
+3,980
New +$990K 0.01% 954
2020
Q2
Sell
-5,156
Closed -$1.38M 2348
2020
Q1
$1.38M Sell
5,156
-2,996
-37% -$802K 0.04% 583
2019
Q4
$2.64M Sell
8,152
-6,135
-43% -$1.99M 0.02% 724
2019
Q3
$3.9M Buy
+14,287
New +$3.9M 0.03% 547
2019
Q1
Sell
-9,899
Closed -$4.88M 2295
2018
Q4
$4.88M Sell
9,899
-5,719
-37% -$2.82M 0.06% 406
2018
Q3
$14.3M Buy
15,618
+11,775
+306% +$10.8M 0.17% 157
2018
Q2
$2.82M Buy
+3,843
New +$2.82M 0.04% 536
2017
Q3
Sell
-916
Closed -$269K 1777
2017
Q2
$269K Buy
+916
New +$269K 0.01% 1171
2016
Q4
Sell
-1,469
Closed -$379K 1869
2016
Q3
$379K Buy
1,469
+589
+67% +$152K 0.03% 657
2016
Q2
$188K Sell
880
-3,164
-78% -$676K 0.01% 905
2016
Q1
$834K Buy
+4,044
New +$834K 0.06% 439